Related by context. Frequent words. (Click for all words.) 70 Venous Thromboembolism 68 Survival Rates 67 Systematic Review 67 Elderly Patients 67 Gastric Cancer 67 Atopic Dermatitis 66 Racial Disparities 66 Allergic Rhinitis 66 Breast Cancer Treatment 66 Prostate Cancer Patients 66 Autoimmune Disease 66 Drug Pipeline 65 Dyslipidemia 65 Meta Analysis 65 Reduces Risk 65 Urinary Incontinence 65 Cancer Therapies 65 Overactive Bladder 64 Pulmonary Arterial Hypertension 64 Postmenopausal Women 64 Newly Diagnosed 64 Drug Resistant 64 Cancer Treatments 64 Acute Coronary Syndromes 64 Patient Outcomes 64 Lung Cancer Patients 63 Clinical Trial Results 63 Patients Undergoing 63 Gum Disease 63 Study Indicates 63 Increases Risk 63 Urinary Tract Infections 63 Patient Enrollment 63 Medication Errors 63 Autoimmune Diseases 63 Genetic Testing 63 Regimens 63 Surgical Treatment 63 Significantly Reduces 63 Novel Approach 63 Monoclonal Antibodies 63 Benign Prostatic Hyperplasia 63 Phase III Trial 63 Blood Thinner 62 Pediatric Patients 62 Study Identifies 62 Study Demonstrates 62 Advanced Prostate Cancer 62 Cognitive Decline 62 Prostate Cancer Treatment 62 Hormone Therapy 62 Pipeline Analysis 62 Drug Candidate 62 Heart Failure Patients 62 Cholesterol Drug 61 Hepatitis C Virus 61 Early Diagnosis 61 Cost Effectiveness 61 RNAi Therapeutics 61 Stomach Cancer 61 Molecular Cancer 61 Insulin Resistance 61 Brain Tumors 61 Randomized Controlled Trial 61 Diabetic Patients 61 Bladder Cancer 61 Treatment Options 61 Report companiesandmarkets.com adds 61 Patient Registry 60 Drug Makers 60 Risks Associated 60 Antipsychotic 60 Breast Cancer Patients 60 Cervical Cancer Vaccine 60 Protects Against 60 Chronic Heart Failure 60 Smallpox Vaccine 60 Single Dose 60 Cancer Vaccines 60 Related Deaths 60 Treatable 60 Quitting Smoking 60 Vitamin D Deficiency 60 Catheterization 60 Ear Infections 60 Inc Therapeutic Competitors 60 Clinical Outcomes 60 Holds Promise 60 Metastatic Colorectal Cancer 59 FDA Accepts 59 Report Analyzes 59 Childhood Asthma 59 Cancer Immunotherapy 59 Preclinical Data 59 Combination Therapy 59 Medicare Beneficiaries 59 Cardiovascular Events 59 Tumor Growth 59 Phase III Clinical Trial 59 Reduce Risk 59 Low Dose